CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. — المؤلف: Xue, Yibo — Nature communications 20190410
- المؤلف
- Xue, Yibo
- النشر
- Nature communications 20190410
- الوصف
- 558 p.
- الموضوعات
- Aminopyridines؛ Animals؛ Benzimidazoles؛ Carcinoma, Small Cell؛ Cell Line, Tumor؛ Cell Survival؛ Chromatin Immunoprecipitation؛ Cyclin D1